Log In
BCIQ
Print this Print this
 

atrasentan

Also known as: Xinlay (ABT-627)

  Manage Alerts
Collapse Summary General Information
Company AbbVie Inc.
DescriptionEndothelin A receptor antagonist
Molecular Target Endothelin A receptor
Mechanism of ActionEndothelin A receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationDiabetic nephropathy
Indication DetailsTreat diabetic nephropathy
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today